m(6)A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD

Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer worldwide. However, the survival rate of LUAD patients remains low. N6-methyladenosine (m(6)A) and long noncoding RNAs (lncRNAs) play vital roles in the prognostic value and the immunotherapeutic response of LUAD. Thus, discernin...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Feng, Huang, Xiaoling, Li, Yangyi, Chen, Yongsong, Lin, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094594/
https://www.ncbi.nlm.nih.gov/pubmed/33996259
http://dx.doi.org/10.1016/j.omtn.2021.04.003

Ejemplares similares

Ejemplares similares